Health Boards
›
Psoriasis In The News
Vitae announce RORyt Inhibitor VTP-43742 phase 1 results
|
Vitae announce RORyt Inhibitor VTP-43742 phase 1 results
|
Sat-12-09-2015, 19:13 PM
(Sat-12-09-2015, 16:58 PM)AmandaL Wrote: Don't know if I trust them. It's inflammatory bowel disease not irritable Good observation Amanda, I can see your point. Tut Tut Vitae Pharmaceuticals, you should spend a little time checking what you say.  *That'll make the Brandwatch Bot get a little excited. 
|
|
« Next Oldest | Next Newest »
|
| Messages In This Thread |
|
Vitae announce RORyt Inhibitor VTP-43742 phase 1 results - by Fred - Tue-08-09-2015, 21:57 PM
RE: Vitae announce RORyt Inhibitor VTP-43742 phase 1 results - by AmandaL - Sat-12-09-2015, 16:58 PM
RE: Vitae announce RORyt Inhibitor VTP-43742 phase 1 results - by Fred - Sat-12-09-2015, 19:13 PM
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
Zoryve for psoriasis phase 3 results | Fred | 3 | 603 |
Wed-11-06-2025, 14:16 PM Last Post: Fred |
|
|
Icotrokinra results for new psoriasis pill | Fred | 3 | 1,055 |
Thu-10-04-2025, 14:44 PM Last Post: Fred |
|
|
Sotyktu for psoriasis 4 year results | Fred | 2 | 731 |
Sat-08-03-2025, 11:50 AM Last Post: Fred |
|
|
Topical TYK2 inhibitor and psoriasis | Fred | 0 | 530 |
Wed-05-03-2025, 13:54 PM Last Post: Fred |
|
|
Skyrizi palmoplantar pustular psoriasis results | Fred | 0 | 590 |
Fri-28-02-2025, 14:09 PM Last Post: Fred |
